UDP-GlcNAc (UDP-N-acetylglucosamine) and UDP-GlcA (UDP-glucuronic acid) were oxidized by periodate in the ribose ring and utilized as inhibitors for hyaluronate synthase in membrane fractions from the B6 cell line and in cell cultures of B6 cells and human fibrosarcoma HT 1080. Inhibition was irreversible and concentrationdependent and could be prevented in the case of periodate-oxidized UDP-GlcNAc by UDP-GlcNAc. Periodate-oxidized UDP-GlcNAc was shown to block chain elongation of hyaluronate. Introduction of periodate-oxidized UDP-GlcA into B6 cells by hypo-osmotic lysis of pinocytotic vesicles decreased hyaluronate synthesis by direct inhibition of the synthase. In HT 1080 cells the synthesis of hyaluronate, chondroitin sulphate and heparan sulphate was inhibited simultaneously.
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Hyaluronate is synthesized at the inner side of the plasma membrane by alternate transfer of UDP-hyaluronate to the substrates UDP-GlcNAc and UDP-GlcA, and the growing chain is extruded through the membrane to the extracellular matrix (Prehm, 1983a (Prehm, ,b, 1984 . The synthesis of hyaluronate could not be inhibited by tunicamycin (Hart & Lennarz, 1978) , xylosides (Hopwood & Dorfman, 1977) or other drugs (Mapleson & Buchwald, 1981; Mitchell & Hardingham, 1982) , since neither lipid carriers nor protein primers are involved. The effect of hyaluronate on cellular behaviour could therefore only be studied indirectly by either hyaluronidase treatment of cultured cells or by comparison of cell lines exhibiting altered hyaluronate production (Toole, 1981) . With the knowledge of the mechanism of hyaluronate synthesis it is possible to design inhibitors that interfere with the assembly of the hyaluronate chain. Appropriate inhibitors would be analogues of the precursors UDP-GlcNAc and UDP-GlcA selectively oxidized in the ribose moiety by periodate. Although periodate-oxidized nucleotides have been used as inhibitors and affinity labels for a variety of enzymes (Jacoby & Wilchek, 1977; Plapp, 1982; Colman, 1983) oxidized UDP-GlcNAc and UDP-GlcA in isolated membranes and in cell culture.
Materials and methods
Materials and growth of the B6 cell line were described previously (Prehm, 1984) . The human fibrosarcoma cell line HT 1080 was obtained from the American Type Culture Collection. Periodateoxidized UDP was obtained from Sigma. Particulate fractions of B6 cells containing high hyaluronate synthase activity were obtained from B6 cells grown to a density of 106 cells/ml and stimulated for 6h by the addition of 5% (v/v) foetal-bovine serum. Cells were harvested by centrifugation at 1 500g for IOmin, washed with phosphate-buffered saline (8g of NaCl, 0.2g of KCI, l.15g of Na2HPO4, 0.2g of KH2PO4 dissolved in 1 litre of water, pH7.3) and suspended at 108 cells/ml in phosphate-buffered saline at 4°C. The cells were disrupted in a Parr-bomb for 10min at 5.07MPa (S0atm) (Evans, 1979 acetic acid, suspended in 1 ml of water and 0.5 ml was withdrawn for determination of radioactivity.
Results
Periodate oxidation ofUDP-GlcNAc and UDP-GlcA UDP-GlcNAc and UDP-GlcA were oxidized with periodate under mild conditions. The periodate-oxidized products were analysed by ionexchange chromatography and t.l.c. The contents of GlcNAc and GlcA was determined by the carbazole method (Bitter & Muir, 1962) and with dimethylaminobenzaldehyde (Reissig et al., 1956) respectively. In each case the periodate-oxidized products were chromatographically homogeneous and gave quantitatively the predicted values for intact carbohydrates. The n.m.r. spectra of o-UDP-GlcNAc and o-UDP-GlcA gave proton signals for the sugar moieties similar to those of the reference compounds GlcNAc and GlcA respectively. However, free aldehyde groups were not found, because adjacent aldehydes form cyclic acetals by addition of water, as shown for periodate-oxidized uridine (Hansske & Cramer, 1977 presence of lOOpM-o-UDP-GlcNAc (Fig. 1) . A Dixon plot of the initial velocity of hyaluronate synthesis showed non-linearity, indicating that the inhibition is irreversible (Fig. 2) . The time course of hyaluronate synthase inactivation is shown in Fig. 3 . The inactivation was biphasic, with a rapid decrease during the initial 30min, followed by a slower phase. The rate of inactivation of hyaluronate synthase by o-UDP-GlcNAc and o-UDP-GlcA was concentration-dependent, and a plot of the initial inactivation rates versus reagent concentration gave hyperbolic curves tending towards a maximum (Fig. 4) . Fig. 3 illustrates that hyaluronate synthase is partially inactivated by incubation of the particulate fraction with 100 /M-o-UDP-G1cA and lOO1uM-UDP-GlcNAc for 30min. The natural substrate, UDP-GlcNAc, could protect the enzyme only against o-UDP-GlcNAc, but not against o-UDP-GlcA. It was, however, not protected against o-UDP-GlcA by UDP-GlcNAc or UDP-GlcA (Table 1) The particulate fraction (100 ul) from B6 cells was incubated at 37°C with either 40mM-phosphate buffer, pH 6.8, or phosphate buffer, pH 6.8, containing the listed compounds (100pM) for 30min. The hyaluronate synthase activity was sedimented at lOOOOg for 3min, washed with 0.5 ml of phosphate buffer and determined as described in Fig. 2 (Fig. 6 ).
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. Inhibition of cellular glycosaminoglycan synthesis o-UDP-GlcA was introduced into the cytosol of B6 cells by hypo-osmotic lysis of pinocytotic vesicles (Okada & Rechsteiner, 1982) . Table 2 demonstrates the concentration-dependent inhibition of the production of hyaluronate, which is shed into the medium for 24h after uptake of the inhibitor. At this time the hyaluronate synthase activity was determined from the same cells (Table  2) . Since B6 cells produce hyaluronate as the only detectable glycosaminoglycan, the effect of o-UDP-GlcA on proteoglycans was studied on the human fibrosarcoma cell line HT 1080. In the same experiment the natural substrate UDP-GlcA was also introduced into the cytosol. Proteoglycan production was measured by metabolic labelling of glycosaminoglycans in the medium with [3H]GlcN (Fig. 7) .
Discussion When periodate oxidation is performed under mild conditions with equimolar amounts of NaIO4, vicinal hydroxy groups in cis positions are oxidized faster than those in the trans positions (Bobbit, 1956; Guthrie, 1961) . In UDP-GlcNAc and UDP-GlcA the ribose ring is therefore more susceptible than are the GlcNAc or GlcA moieties. Quantitative analysis of the GlcA and GlcNAc content in the periodate-oxidized nucleotide sugars indicated that GlcA and GlcNAc remained intact and the ribose was altered to cyclic acetals. These compounds were applied as inhibitors of hyaluronate synthase.
Inhibition was irreversible and, in the case of o-UDP-GlcNAc (but not o-UDP-GlcA), could be prevented by the natural substrate. A 10-fold higher concentration of o-UDP is needed to inactivate hyaluronate synthase to the same extent as the periodate-oxidized nucleotide sugars, indicating that the enzyme specifically recognized the sugar moieties. The initial inactivation rates of hyaluronate synthase reached a maximum with increasing inhibitor concentrations (Fig. 5) . Such behaviour indicates that inactivation occurs in two steps, in which reversible binding ofthe inhibitor to the enzyme precedes covalent binding (Meloche, 1967) .
The observation that UDP-GlcNAc could protect the enzyme from o-UDP-GlcNAc and that o-UDP-GlcNAc and o-UDP-GlcA inactivated the enzyme to about 50% in the initial rapid phase (Figs. 4 and 6) could be interpreted as follows. Hyaluronate synthase contains active sites for each of the nucleotide sugars, one of which is alternately occupied by the end of the hyaluronate chain. Thus 50% of the hyaluronate synthase would be accessible to the inhibitors for inactivation. If transfer of the chain to the inhibitor molecule occurred at a low rate, then the active site for the other inhibitor becomes susceptible. The inhibition studies suggested that the periodate-oxidized nucleotide sugars behave as affinity labels for the site at which the nucleotide sugars bind to hyaluronate synthase.
o-UDP-GlcA blocked chain elongation of hyaluronate (Fig. 7) , which may serve as additional evidence that hyaluronate is elongated at the reducing end by alternate addition of the chain to new substrate. If hyaluronate chains were elongated at the non-reducing end, the residual active synthase would be expected to elongate all chains further, although at a lower rate. These inhibitors can therefore discriminate between these two chain-elongation mechanisms.
Since these inhibitors are the first documented compounds to interfere directly with hyaluronate synthesis, they provide valuable tools for inhibition of hyaluronate synthesis in cell culture. Introduction of o-UDP-GlcA into the cytosol of living cells by hypo-osmotic lysis of pinocytotic vesicles inhibited hyaluronate synthesis by inactivation of the synthase (Table 2 ). In HT 1080 cells hyaluronate and proteoglycan syntheses were simultaneously inhibited by o-UDP-GlcA. Introduction of the natural substrate, UDP-GlcA, into HT 1080 cells also inhibited the synthesis of heparan sulphate and chondroitin sulphate, whereas hyaluronate synthesis was further stimulated. The compounds had no influence of protein synthesis.
With these periodate-oxidized nucleotide sugars it may now be possible to study the function of hyaluronate on cellular behaviour directly.
